MB‘åŠwˆãŠw•” •ªŽq•a‘ÔŠw‹³Žº


“Á”C‹³Žö@ÂŽR@‘ô–@HEADLINE

@

Žå—v˜_•¶


œ Okamoto C, Hayakawa Y, Aoyama T, Komaki H, Minatoguchi S, Iwasa M, Yamada Y, Kanamori H, Kawasaki M, Nishigaki K, Mikami A, Minatoguchi S. Excessively low salt diet damages the heart through activation of cardiac (pro) renin receptor, renin-angiotensin-aldosterone, and sympatho-adrenal systems in spontaneously hypertensive rats. PLoS One. 12(12):e0189099. 2017.
œYokoyama C, Aoyama T, Ido T, Kakino A, Shiraki T, Tanaka T, Nishigaki K, Hasegawa A, Fujita Y, Sawamura T, Minatoguchi S. Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin. PLoS One. 11(5):e0154994. 2016 (Ó”C’˜ŽÒ)
œHayakawa Y, Aoyama T, Yokoyama C, Okamoto C, Komaki H, Minatoguchi S, Iwasa M, Yamada Y, Kawamura I, Kawasaki M, Nishigaki K, Mikami A, Suzuki F, Minatoguchi S. High salt intake damages the heart through activation of cardiac (pro) renin receptors even at an early stage of hypertension. PLoS One. 10(3):e0120453. 2015.
œShiraki T, Aoyama T, Yokoyama C, Hayakawa Y, Tanaka T, Nishigaki K, Sawamura T, Minatoguchi S. LOX-1 plays an important role in ischemia-induced angiogenesis of limbs. PLoS One. 9(12):e114542. 2014. (Ó”C’˜ŽÒ)
œTakahashi S, Kawasaki M, Miyata S, Suzuki K, Yamaura M, Ido T, Aoyama T, Fujiwara H, Minatoguchi S. Feasibility of tissue characterization of coronary plaques using 320-detector row computed tomography: comparison with integrated backscatter intravascular ultrasound. Heart Vessels. 31(1):29-37. 2014
œHattori A, Kawamura I, Yamada Y, Kanamori H, Aoyama T, Ushikoshi H, Kawasaki M, Nishigaki K, Tamemura G, Minatoguchi S. Elevated plasma GLP-1 levels and enhanced expression of cardiac GLP-1 receptors as markers of left ventricular systolic dysfunction: a cross-sectional study. BMJ Open. 3(9):e003201. 2013
œMinatoguchi S, Aoyama T, Kawai N, Iwasa M, Oda M, Kida K, Kojima S, Goto N, Goto M, Sugishita F, Takai K, Tanaka R, Hiei K, Minagawa T, Yamamoto N, Watanabe I, Yasue T, Kobayashi H. Comparative effect of candesartan and amlodipine, and effect of switching from valsartan, losartan, telmisartan and olmesartan to candesartan, on early morning hypertension and heart rate. Blood Press.:29-37. 2013
œYamada Y, Kobayashi H, Iwasa M, Sumi S, Ushikoshi H, Aoyama T, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Kiso M, Minatoguchi S. Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits. Am J Physiol Heart Circ Physiol. 304(8):H1124-33. 2013
œIwasa M, Yamada Y, Kobayashi H, Yasuda S, Kawamura I, Sumi S, Shiraki T, Yamaki T, Ushikoshi H, Hattori A, Aoyama T, Nishigaki K, Takemura G, Fujiwara H, Minatoguchi S. Both stimulation of GLP-1 receptors and inhibition of glycogenolysis additively contribute to a protective effect of oral miglitol against ischaemia-reperfusion injury in rabbits. Br J Pharmacol. 164(1):119-31. 201
œKawamura I, Takemura G, Kanamori H, Takeyama T, Kawaguchi T, Tsujimoto A, Goto K, Maruyama R, Watanabe T, Shiraki T, Aoyama T, Fujiwara T, Fujiwara H, Minatoguchi S. Repeated phlebotomy augments angiogenesis to improve blood flow in murine ischemic legs. Am J Physiol Heart Circ Physiol. H372-8. 2010
œAoyama T, Matsui T, Novikov M, Park J, Hemmings B, Rosenzweig A. Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response. Circulation. 111(13):1652-9. 2005 i•M“ª’˜ŽÒj
œNagoshi T, Matsui T, Aoyama T, Leri A, Anversa P, Li L, Ogawa W, del Monte F, Gwathmey JK, Grazette L, Hemmings B, Kass DA, Champion HC, Rosenzweig A. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest. 115(8):2128-38. 2005
œAoyama T, Takemura G, Maruyama R, Kosai K, Takahashi T, Koda M, Hayakawa K, Kawase Y, Minatoguchi S, Fujiwara H. Molecular mechanisms of non-apoptosis by Fas stimulation alone versus apoptosis with an additional actinomycin D in cultured cardiomyocytes. Cardiovasc Res. 55(4):787-98. 2002 i•M“ª’˜ŽÒj
œAoyama T. Chen, M. Fujiwara, H Masaki, T. Sawamura, T. LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells. FEBS Lett 467: 217-20. 2000 i•M“ª’˜ŽÒj
œAoyama T. Fujiwara, H. Masaki, T. Sawamura, T. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells. J Mol Cell Cardiol 31: 2101-14. 1999 i•M“ª’˜ŽÒj
œAoyama T. Sawamura, T. Furutani, Y. Matsuoka, R. Yoshida, M. C. Fujiwara, H. Masaki, T. Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene. Biochem J 339: 177-84. 1999 i•M“ª’˜ŽÒj
œKanoh, M. Takemura, G. Misao, J. Hayakawa, Y. Aoyama T. Nishigaki, K. Noda, T. Fujiwara, T. Fukuda, K. Minatoguchi, S. Fujiwara, H.  Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation. 99: 2757-64. 1999
œMoriwaki, H. Kume, N. Sawamura, T. Aoyama T. Hoshikawa, H. Ochi, H. Nishi, E. Masaki, T. Kita, T. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol 18: 1541-7. 1998
œKume, N. Murase, T. Moriwaki, H. Aoyama T. Sawamura, T. Masaki, T. Kita, T. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 83: 322-7. 1998
œSawamura, T. Kume, N. Aoyama T. Moriwaki, H. Hoshikawa, H. Aiba, Y. Tanaka, T. Miwa, S. Katsura, Y. Kita, T. Masaki, T. An endothelial receptor for oxidized low-density lipoprotein. Nature 386: 73-7. 199